Loss-of-function variants in CTSA can cause GS, characterized by a range of symptoms affecting the central nervous system, as well as the vision and hearing, cardiovascular, gastrointestinal, urinary, skin, blood, skeletal and connective tissue systems. This evidence concerns the gene CTSA and Gerstmann syndrome.